New treatment strategies for pulmonary arterial hypertension: Hopes or hypes?

Journal of the American College of Cardiology

Volumn 62, Issue 12, 2013, Pages 1101-1102

  Galiè, Nazzareno ^a   Manes, Alessandra ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

6 min walk test; denervation; pulmonary artery hypertension; pulmonary artery pressure

Indexed keywords

ENDOTHELIN RECEPTOR ANTAGONIST; IMATINIB; PHOSPHODIESTERASE V INHIBITOR; PROSTANOID; SITAXSENTAN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ABLATION THERAPY; DENERVATION; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; KIDNEY DENERVATION; LIVER TOXICITY; NOTE; PATIENT SAFETY; PRIORITY JOURNAL; PULMONARY ARTERY DENERVATION; PULMONARY HYPERTENSION; STEM CELL TRANSPLANTATION; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 84883765860     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.06.032     Document Type: Editorial

References (11)

1. N. Galiè, M. Hoeper, and M. Humbert Guidelines on diagnosis and treatment of pulmonary hypertension: the Task Force on Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology and of the European Respiratory Society Eur Heart J 30 2009 2493 2537
2. N. Galiè, A. Manes, L. Negro, M. Palazzini, M.L. Bacchi Reggiani, and A. Branzi A meta-analysis of randomized controlled trials in pulmonary arterial hypertension Eur Heart J 30 2009 394 403
3. Y. Bai, L. Sun, S. Hu, and Y. Wei Combination therapy in pulmonary arterial hypertension: a meta-analysis Cardiology 120 2011 157 165
4. S.-L. Chen, F-F. Zhang, and J. Xu Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (First-in-Man Pulmonary Artery Denervation for Treatment of Pulmonary Artery Hypertension) J Am Coll Cardiol 62 2013 1092 1100
5. S.L. Chen, Y.J. Zhang, and L. Zhou Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo EuroIntervention 9 2013 269 276
6. J. Żyłkowska, M. Kurzyna, and M. Florczyk Pulmonary artery dilatation correlates with the risk of unexpected death in chronic arterial or thromboembolic pulmonary hypertension Chest 142 2012 1406 1416
7. V. Petkov, W. Mosgoeller, and R. Ziesche Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension J Clin Invest 111 2003 1339 1346
8. N. Galiè Effects of inhaled aviptadil (vasoactive intestinal peptide) in patients with pulmonary arterial hypertension (PAH) (abstr) Am J Respir Crit Care Med 181 2010 A2516
9. X.X. Wang, F.R. Zhang, and Y.P. Shang Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial J Am Coll Cardiol 49 2007 1566 1571
10. N. Galiè, M. Hoeper, J.S. Gibbs, G. Simonneau Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Liver toxicity of sitaxentan in pulmonary arterial hypertension Eur Heart J 32 2011 386 387
11. M.M. Hoeper, R.J. Barst, and R.C. Bourge Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study Circulation 127 2013 1128 1138